Animal and Veterinary Innovation Centers (U18)
ID: 355044Type: Posted
Overview

Buyer

Food and Drug Administration (HHS-FDA)

Award Range

$0 - $1M

Eligible Applicants

Others

Funding Category

Food and Nutrition

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355044

Additional Information

https://grants.nih.gov/grants/guide/pa-files/PAR-24-251.html
Timeline
    Description

    The Food and Drug Administration (FDA) is inviting applications for the Animal and Veterinary Innovation Centers (U18) through a Notice of Funding Opportunity (NOFO). This initiative aims to establish long-term partnerships with academic institutions to advance research in critical areas of veterinary health, particularly focusing on interventions against Highly Pathogenic Avian Influenza (HPAI), genomic alterations for agricultural resilience, and addressing unmet veterinary needs for minor species and minor uses in major species. The program is significant for enhancing veterinary innovation and public health integration, with a total funding availability of approximately $3 million for fiscal year 2024, supporting up to eight awards. Interested applicants must submit their proposals by August 5, 2024, following specific guidelines via Grants.gov or NIH ASSIST, and can contact Terrin Brown at terrin.brown@fda.hhs.gov for further information.

    Point(s) of Contact
    terrin.brown@fda.hhs.gov
    Files
    Title
    Posted
    PAR-24-251.html
    The Department of Health and Human Services, through the FDA, has issued a Notice of Funding Opportunity (NOFO) seeking applications for the Animal and Veterinary Innovation Centers (U18). This initiative aims to create partnerships with academic institutions to enhance research addressing critical veterinary health issues, particularly targeting interventions against Highly Pathogenic Avian Influenza (HPAI), genomic alterations to improve agricultural resilience, and unmet veterinary needs for minor species and minor uses in major species. Key dates include an application deadline of August 5, 2024, with a total funding availability of approximately $3 million for fiscal year 2024, supporting up to eight awards. Applicants must follow specific guidelines tailored to FDA processes and submit through Grants.gov or NIH ASSIST. The program particularly encourages participation from diverse educational institutions, including HBCUs and other minority-serving institutions. The applications will be evaluated based on significance, investigator capability, innovative approaches, execution strategy, and the environment’s support. This funding opportunity marks a significant federal effort to boost veterinary innovation and public health integration through targeted research and cooperative agreements across the veterinary medicine landscape.
    Similar Opportunities
    Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering the Vet-LIRN Capacity-Building Project and Equipment Grants (U18) to enhance the capabilities of veterinary diagnostic laboratories within the Vet-LIRN network. This funding opportunity aims to support projects focused on animal food safety, antimicrobial resistance, and surveillance efforts related to foodborne illnesses and emerging diseases, including COVID-19. The initiative is part of the FDA's commitment to improving food safety standards and aligns with the Food Safety Modernization Act, emphasizing the importance of federal involvement in bolstering food safety and containment capabilities. Interested applicants, including small businesses and various institutions, can apply for grants ranging from $225,000 to $2.5 million, with applications accepted annually until September 4, 2028. For further details, contact Kimberly Pendleton at kimberly.pendleton@fda.hhs.gov or visit the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-202.html.
    Minor Use Minor Species Development of Drugs (R01)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is offering a funding opportunity for research grants (R01) aimed at the development of new animal drugs for minor uses in major species or for minor species (MUMS). Eligible applicants include a variety of organizations such as higher education institutions, nonprofits, and for-profit entities engaged in veterinary drug development, with the goal of defraying costs associated with safety and effectiveness testing required for FDA approval of MUMS-designated drugs. This initiative underscores the FDA's commitment to enhancing veterinary medicine for less common uses and species, with funding available up to $250,000 per year for a maximum of three years. Interested parties must have an open Investigational New Animal Drug (INAD) file and a minor use or minor species designation, with application deadlines spanning from July 2024 to January 2027. For further details, applicants can contact Terrin Brown at terrin.brown@fda.hhs.gov.
    Minor Use Minor Species Development of Drugs (R01)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity for the development of drugs for minor uses in major species or for use in minor species through its Minor Use Minor Species Development of Drugs (R01) grant program. This initiative aims to support research projects that assist in the safety and effectiveness testing of new animal drugs designated for minor uses, with a focus on entities that have opened an Investigational New Animal Drug (INAD) file and received the necessary designations from the FDA's Office of Minor Use and Minor Species Animal Drug Development. The program is crucial for enhancing veterinary care options for less common animal species, ensuring that these drugs meet FDA approval standards. Interested applicants can apply for grants with a funding ceiling of $250,000, with an expected six awards available for the fiscal year 2025. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at (240) 402-7610.
    Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a funding opportunity titled "Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives." This cooperative agreement aims to enhance the capabilities of State animal food regulatory programs to fully implement the Animal Feed Regulatory Program Standards (AFRPS) and to develop standardized processes that promote mutual reliance between federal and state regulatory efforts. The initiative is crucial for establishing a nationally integrated animal food safety system, ensuring that state programs can effectively manage animal food safety regulations. Interested organizations must meet specific eligibility criteria, including the ability to enter into a 20.88 information disclosure agreement with the FDA, and the funding amount is set at $10.6 million, with approximately 30 awards expected. For further inquiries, applicants can contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610.
    Animal Food Regulatory Program Alliance
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity titled "Animal Food Regulatory Program Alliance," aimed at enhancing the national food safety system through improved collaboration among federal and state agencies. The primary objective of this program is to support the development of a national integrated animal food safety system, which includes sharing best practices, conducting training programs, and advancing the Animal Food Regulatory Program Standards (AFRPS). This initiative is crucial for ensuring public health and consumer protection in the regulation of manufactured foods. Interested national associations or organizations that represent state animal food regulatory programs can apply for funding, with a total award amount of $600,000. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or call 240-402-7610. The fiscal year for this opportunity is 2025.
    Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a cooperative agreement opportunity for the collection of long-term data on antimicrobial use in animals, with a focus on diverse sectors such as livestock, poultry, and companion animals. The primary objectives of this initiative are to gather comprehensive antimicrobial use data and to contribute to the development of data collection frameworks that support antimicrobial stewardship in veterinary settings. This funding is crucial for advancing the FDA's initiatives and the National Action Plan's goals to enhance understanding and management of antimicrobial use in animal agriculture. Interested small businesses can apply for a total estimated funding of $600,000, with an award ceiling of $200,000 per project, and are encouraged to contact Janelle Fundersburg at janelle.fundersburg@fda.hhs.gov or 301-798-2533 for further information.
    Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is forecasting a grant opportunity titled "Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed." This initiative aims to establish and sustain Rapid Response Teams (RRTs) to enhance the national integrated food safety system by coordinating federal, state, and local emergency response efforts related to human and animal food safety. The program is critical for improving regulatory and surveillance capabilities, ensuring rapid identification and removal of contaminated food, and fostering continuous improvement in response strategies. Interested applicants, including state governments and other entities, can apply for funding ranging from $360,000 to $1,440,000, with an expected four awards to be made. For further inquiries, applicants may contact Terrin Brown at terrin.brown@fda.hhs.gov or by phone at 240-402-7610.
    Collaborations to Enhance Drug Development and Regulatory Science
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is inviting applications for a federal grant titled "Collaborations to Enhance Drug Development and Regulatory Science." This opportunity aims to establish cooperative agreements that support Public-Private Partnerships and collaborative activities under the Critical Path Initiative, focusing on innovative projects that enhance drug product development, advanced manufacturing, and the translation of scientific discoveries into therapeutics. The initiative is crucial for fostering innovation in drug safety, efficacy, quality, and performance, with a total funding ceiling of $5 million available for six expected awards in fiscal year 2024. Interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or call (240) 402-7610 for further information.
    National Animal Disease Preparedness and Response Program Fiscal Year 2025
    Active
    Animal and Plant Health Inspection Service
    The Animal and Plant Health Inspection Service (APHIS) of the U.S. Department of Agriculture (USDA) is offering a funding opportunity through the National Animal Disease Preparedness and Response Program (NADPRP) for Fiscal Year 2025, with a total of up to $16.5 million available. The program aims to enhance the nation's preparedness against foreign and emerging animal diseases by supporting projects that develop and exercise emergency response plans, improve livestock biosecurity, enhance animal disease traceability, and conduct training programs. This initiative is critical for safeguarding U.S. agriculture and aligns with USDA's strategic goals, particularly in addressing the threats posed by animal diseases. Applications are due by October 18, 2024, and eligible applicants include state agriculture departments, veterinary colleges, Indian Tribes, and other relevant organizations. For inquiries, interested parties can contact Julie Wallin at julie.e.wallin@usda.gov or call 970-494-7258.
    Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
    Active
    Food and Drug Administration
    The Food and Drug Administration (FDA) is announcing a funding opportunity for a Cooperative Agreement titled "Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)." This initiative aims to support research and development of practices that mitigate risks associated with nitrosamine impurities in human drugs, thereby enhancing public health safety while ensuring access to essential therapeutic drugs. The FDA seeks to fund one award with a total funding amount of $350,000, with no cost-sharing or matching requirements. Interested applicants can reach out to Terrin Brown at terrin.brown@fda.hhs.gov or (240) 402-7610 for further information. The opportunity is forecasted for fiscal year 2024, and applicants may submit multiple distinct applications, adhering to guidelines regarding overlapping submissions.